Skip to main content
. 2017 Jun 23;35(26):3002–3009. doi: 10.1200/JCO.2017.72.8428

Fig 4.

Fig 4.

The 2-year probabilities of progression-free survival adjusted for age, cytomegalovirus serostatus and disease risk index were 41% (95% CI, 36% to 45%) and 54% (95% CI, 47% to 61%) after bone marrow (BM) and peripheral blood (PB) transplants.